Clinical Trial Update: Effect of PBT2 in Patients With Early to Mid Stage Huntington Disease [Phase 2]

View source ↗

Summary

Phase 2 trial of PBT2 in patients with early to mid-stage Huntington disease has been completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Drugs mentioned

• PBT2

Snippet

Sponsor: Prana Biotechnology Limited | Conditions: Huntington Disease | Phase 2 | Status: COMPLETED | Results posted: 2016-07-18